GFAP and COVID-19: A recent study found elevated levels of neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) among patients admitted for COVID-19, implying that dysregulations in both innate and adaptive immune responses are contributory to neurologic injury in the setting of COVID-19 (8).